You Lü

Tulane University — United States

Medicine · Health Sciences

51h-index12.0kcitations425works2.02yr avg

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Lung Cancer Treatments and Mutations(149), Lung Cancer Diagnosis and Treatment(88), Lung Cancer Research Studies(88), Cancer Immunotherapy and Biomarkers(53), Colorectal Cancer Treatments and Studies(29)

Publications424 total

Integrated metabolome and transcriptome analysis revealed the mechanism of secondary metabolite biosynthesis in Bletilla striata under UV-C treatment

Plant Physiology and Biochemistry·2025

Real-world use of and clinical outcomes with dacomitinib as first-line therapy in Asian patients with EGFR mutation–positive locally advanced or metastatic non-small cell lung cancer: Final analysis of the ARIA study

1 cited

Lung Cancer·2025· 1 cited

Supplementary Data 1 from Safety and Tolerability of Low-Dose Radiation and Stereotactic Body Radiotherapy + Sintilimab for Treatment-Naïve Stage IV PD-L1<sup>+</sup> Non–Small Cell Lung Cancer Patients

2025Open Access

Catalytic reforming of lignite pyrolysis volatiles over metal oxide and zeolite tandem catalysts for light aromatics production

Journal of Fuel Chemistry and Technology·2025Open Access

Abstract 4351129: Life’s Essential 8 Attenuates Premature Mortality Risk in Early-Onset Adult Type 2 Diabetes: Findings from Two Population-Based Studies in the U.S.

Circulation·2025

USP32 facilitates tumor development and is correlated with poor clinical outcomes in hepatocellular carcinoma patients and is modulated by the E2F7/miR-218-5p axis

LabMed discovery.·2025Open Access

Drug allergy history predicts early progression-free survival benefit from PD-(L)1 inhibitors in advanced non-small cell lung cancer: a retrospective cohort study

Clinical & Translational Oncology·2025

Fecal microbiota transplantation plus immune checkpoint inhibitor rechallenges in patients with advanced non-small cell lung cancer: a single-arm exploratory study

Translational Lung Cancer Research·2025Open Access

Application of Nurse-led Family Participatory Rehabilitation Training in Early Rehabilitation of ARDS Patients with Mechanical Ventilation

Journal of Contemporary Medical Practice·2025

AdvanTIG-204: A Phase 2, Randomized, Open-Label Study of Ociperlimab Plus Tislelizumab and Concurrent Chemoradiotherapy Versus Tislelizumab and Concurrent Chemotherapy Versus Concurrent Chemoradiotherapy in First-Line Limited-Stage SCLC

JTO Clinical and Research Reports·2025Open Access

Genetically predicted immunoglobulin G N-glycan profiles as risk and protective factors in dermatitis

Archives of Dermatological Research·2025

Efficacy of regorafenib following first-line immune checkpoint inhibitor failure in patients with advanced hepatocellular carcinoma: A multicenter study

Hepatobiliary & pancreatic diseases international·2025

[Expression of Concern] Downregulation of miR‑145 contributes to lung adenocarcinoma cell growth to form brain metastases

Oncology Reports·2025Open Access

[Expert consensus on the treatment timing calender of congenital ear malformation with multiple malformations].

PubMed·2025

Improving the efficacy of late-line immunotherapy for advanced esophageal cancer: the addition of local radiotherapy

Therapeutic Advances in Gastroenterology·2025Open Access

Differential Survival Benefits of PORT in AJCC-9th /IASLC-Defined N2 NSCLC Substages: A Multicenter Real-World Study

International Journal of Radiation Oncology*Biology*Physics·2025

The Effect of Integrated Management under 8S Mode on the Detection Rate of MDROs and the Qualified Rate of ICU High-frequency Contact Objects

Journal of Contemporary Medical Practice·2025Open Access

Combining immune checkpoint inhibitors with thoracic radiotherapy enhances outcomes in advanced non-small-cell lung cancer: a real-world study

1 cited

Frontiers in Oncology·2025· 1 citedOpen Access

ELAVL3 Controls Neuroendocrine State Plasticity in Small Cell Lung Cancer Through Regulation of NOTCH2 Signaling Pathway RNA Translation

Journal of Thoracic Oncology·2025

Biliary stenting implantation with 125I seed strand followed by chemotherapy plus PD-1 inhibitor in cholangiocarcinoma with malignant obstructive jaundice: a retrospective comparative study

Japanese Journal of Clinical Oncology·2025

page 1 of 22Next →

Frequent Co-authors

Jianxin Xue(12), Yuquan Wei(12), Jianying Zhou(9), Lin Zhou(8), Meijuan Huang(7), Lei Deng(6), Tony Mok(6), Yi‐Long Wu(6), Shun Lü(6), Jifeng Feng(6), Ying Cheng(6), Ruizhan Tong(5), Baohui Han(5), Zhehai Wang(5), Ling Tian(5), Feng Luo(5), Yu Jiang(5), Jie Lan(5), Guangping Gao(4), Roberto Calcedo(4)